Fig. 2From: Vildagliptin has the same safety profile as a sulfonylurea on bone metabolism and bone mineral density in post-menopausal women with type 2 diabetes: a randomized controlled trialProgression of osteocalcin (a) and CTX (b) serum levels during the 12-month period (p values calculated for differences between means in months 6 and 12 versus baseline)Back to article page